NovaBay Pharmaceuticals (NYSE:NBY) Shares Up 2.6% – Here’s Why

NovaBay Pharmaceuticals, Inc. (NYSE:NBY)’s share price rose 2.6% on Wednesday . The stock traded as high as $0.63 and last traded at $0.63. Approximately 9,961 shares changed hands during trading, a decline of 92% from the average daily volume of 123,537 shares. The stock had previously closed at $0.61.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen initiated coverage on NovaBay Pharmaceuticals in a research note on Tuesday, May 20th. They issued a “hold” rating on the stock.

NovaBay Pharmaceuticals Stock Up 2.6%

The firm has a 50 day moving average price of $0.58 and a 200 day moving average price of $0.61. The stock has a market cap of $3.64 million, a PE ratio of -0.01 and a beta of 0.43.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.